Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Topotecan (parenteral) IV

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCTHO1595

    03/25/2016

    An Open-label, Randomized, Phase 3 Study of Nivolumab or Chemotherapy in Subjects with Relapsed Small-cell Lung Cancer after Platinum-based First Line Chemotherapy


    Print this page for your doctor